These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28797494)

  • 61. Culture-Based Techniques.
    Willinger B
    Methods Mol Biol; 2017; 1508():195-207. PubMed ID: 27837505
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fungal infections in ICU patients: epidemiology and the role of diagnostics.
    Morace G; Borghi E
    Minerva Anestesiol; 2010 Nov; 76(11):950-6. PubMed ID: 21102391
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Diagnosis of invasive fungal infection: current status and future prospect].
    Li RY
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1449-50. PubMed ID: 16061019
    [No Abstract]   [Full Text] [Related]  

  • 64. In situ hybridization for rRNA sequences in anatomic pathology specimens, applications for fungal pathogen detection: a review.
    Montone KT; Guarner J
    Adv Anat Pathol; 2013 May; 20(3):168-74. PubMed ID: 23574773
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reverse line blot hybridization assay for identification of medically important fungi from culture and clinical specimens.
    Zeng X; Kong F; Halliday C; Chen S; Lau A; Playford G; Sorrell TC
    J Clin Microbiol; 2007 Sep; 45(9):2872-80. PubMed ID: 17634313
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Advances and challenges in management of invasive mycoses.
    Patterson TF
    Lancet; 2005 Sep 17-23; 366(9490):1013-25. PubMed ID: 16168784
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Detection of bacterial pathogens from clinical specimens using conventional microbial culture and 16S metagenomics: a comparative study.
    Abayasekara LM; Perera J; Chandrasekharan V; Gnanam VS; Udunuwara NA; Liyanage DS; Bulathsinhala NE; Adikary S; Aluthmuhandiram JVS; Thanaseelan CS; Tharmakulasingam DP; Karunakaran T; Ilango J
    BMC Infect Dis; 2017 Sep; 17(1):631. PubMed ID: 28927397
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rapid identification of fungal pathogens by rolling circle amplification using Fonsecaea as a model.
    Najafzadeh MJ; Sun J; Vicente VA; de Hoog GS
    Mycoses; 2011 Sep; 54(5):e577-82. PubMed ID: 21910759
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of fluorescence in situ hybridisation (FISH) for the detection of fungi directly from blood cultures and cerebrospinal fluid from patients with suspected invasive mycoses.
    Da Silva RM; Da Silva Neto JR; Santos CS; Frickmann H; Poppert S; Cruz KS; Koshikene D; De Souza JV
    Ann Clin Microbiol Antimicrob; 2015 Jan; 14():6. PubMed ID: 25637361
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Microbiological laboratory diagnostics of neglected zoonotic diseases (NZDs).
    Schwarz NG; Loderstaedt U; Hahn A; Hinz R; Zautner AE; Eibach D; Fischer M; Hagen RM; Frickmann H
    Acta Trop; 2017 Jan; 165():40-65. PubMed ID: 26391646
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Recognition of Diagnostic Gaps for Laboratory Diagnosis of Fungal Diseases: Expert Opinion from the Fungal Diagnostics Laboratories Consortium (FDLC).
    Zhang SX; Babady NE; Hanson KE; Harrington AT; Larkin PMK; Leal SM; Luethy PM; Martin IW; Pancholi P; Procop GW; Riedel S; Seyedmousavi S; Sullivan KV; Walsh TJ; Lockhart SR;
    J Clin Microbiol; 2021 Jun; 59(7):e0178420. PubMed ID: 33504591
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Advances in non-cultured laboratory diagnosis for etiology of invasive fungal diseases].
    Shi Y; Zhao JN
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jul; 42(7):500-505. PubMed ID: 31365965
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Laboratory Diagnostic Capacity for Fungal Infections in Nigerian Tertiary Hospitals: A Gap Analysis Survey.
    Osaigbovo II; Oladele RO; Orefuwa E; Akanbi OA; Ihekweazu C
    West Afr J Med; 2021 Nov; Vol. 38(11):1065-1071. PubMed ID: 34919363
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Challenges in Serologic Diagnostics of Neglected Human Systemic Mycoses: An Overview on Characterization of New Targets.
    Inácio MM; Cruz-Leite VRM; Moreira ALE; Mattos K; Paccez JD; Ruiz OH; Venturini J; de Souza Carvalho Melhem M; Paniago AMM; de Almeida Soares CM; Weber SS; Borges CL
    Pathogens; 2022 May; 11(5):. PubMed ID: 35631090
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Molecular methods as a diagnostic tool for fungal infections and their prospect].
    Makimura K
    Nihon Ishinkin Gakkai Zasshi; 2004; 45(2):59-62. PubMed ID: 15118660
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of Mycoses in Developing Countries.
    Arastehfar A; Wickes BL; Ilkit M; Pincus DH; Daneshnia F; Pan W; Fang W; Boekhout T
    J Fungi (Basel); 2019 Sep; 5(4):. PubMed ID: 31569472
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 1,3-β-D-glucan in cryptococcal meningitis.
    Rhein J; Boulware DR; Bahr NC
    Lancet Infect Dis; 2015 Oct; 15(10):1136-1137. PubMed ID: 26461948
    [No Abstract]   [Full Text] [Related]  

  • 78. Recent Advances and Novel Approaches in Laboratory-Based Diagnostic Mycology.
    White LP; Price JS
    J Fungi (Basel); 2021 Jan; 7(1):. PubMed ID: 33440757
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular diagnostics for invasive fungal infections: a call for refinement and implementation.
    Procop GW
    J Mol Diagn; 2010 Jan; 12(1):17-9. PubMed ID: 20007842
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Revised Definitions for Invasive Fungal Diseases: Some Advances But Questions Remain.
    Mafaciolli R; Pasqualotto AC
    Clin Infect Dis; 2020 Dec; 71(9):2541-2542. PubMed ID: 32006011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.